Ikena Oncology (IMA) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Ikena Oncology (IMA).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | - | -1.29M | - | 1.29M (+61.25%) | 800K | -4.03M | 3.50M (+82.29%) | 1.92M (-9.00%) | 2.11M (+219.70%) | 660K (-44.54%) | 1.19M (-40.50%) | 2.00M (-62.34%) | 5.31M (-2.57%) | 5.45M (-14.84%) | 6.40M (+1584.21%) | 380K (-88.76%) | 3.38M (-83.28%) | 20M (+439.20%) | 3.75M (+5.63%) | 3.55M (+2.31%) | 3.47M (+4857.14%) | 70K (-97.53%) | 2.83M (-7.82%) | 3.07M (-4.95%) | 3.23M |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 5.96M (+21.63%) | 4.90M (-68.51%) | 16M (+286.10%) | 4.03M (-0.25%) | 4.04M (-53.83%) | 8.75M (+124.94%) | 3.89M (-60.43%) | 9.83M (+1.87%) | 9.65M (-32.38%) | 14M (-2.59%) | 15M (-3.43%) | 15M (-2.44%) | 16M (-0.58%) | 16M (-17.03%) | 19M (+21.69%) | 15M (+8.02%) | 14M (+16.21%) | 12M (-7.77%) | 13M (+17.68%) | 11M (+13.47%) | 10M (-57.18%) | 23M (+224.10%) | 7.22M (+14.06%) | 6.33M (-19.77%) | 7.89M |
Selling General And Administrative | 6.12M (+142.86%) | 2.52M (-77.17%) | 11M (+149.77%) | 4.42M (+60.14%) | 2.76M | -4.57M | 1.65M (-68.93%) | 5.31M (-11.50%) | 6.00M (-27.62%) | 8.29M (+37.48%) | 6.03M (+13.35%) | 5.32M (+0.76%) | 5.28M (+7.10%) | 4.93M (-9.21%) | 5.43M (-7.18%) | 5.85M (-2.50%) | 6.00M (+17.88%) | 5.09M (+4.09%) | 4.89M (+0.62%) | 4.86M (+53.31%) | 3.17M (+16.97%) | 2.71M (+47.28%) | 1.84M (+2.22%) | 1.80M (-28.29%) | 2.51M |
Operating Expenses | 12M (+69.90%) | 7.11M (-73.26%) | 27M (+203.89%) | 8.75M (+28.68%) | 6.80M (+639.13%) | 920K (-83.39%) | 5.54M (-64.98%) | 16M (-13.22%) | 18M (-19.23%) | 23M (+9.09%) | 21M (+0.98%) | 20M (-1.63%) | 21M (+1.26%) | 21M (-15.28%) | 24M (+13.83%) | 21M (+4.82%) | 20M (+16.75%) | 17M (-4.60%) | 18M (+12.50%) | 16M (+23.12%) | 13M (-49.50%) | 26M (+188.30%) | 9.06M (+11.44%) | 8.13M (-21.83%) | 10M |
Depreciation And Amortization | - | 400K | - | - | - | 880K | - | - | 220K (-72.15%) | 790K | - | - | 230K (-59.65%) | 570K | - | - | 180K (-30.77%) | 260K (+160.00%) | 100K (0.00%) | 100K (+11.11%) | 90K (+200.00%) | 30K (-70.00%) | 100K (0.00%) | 100K (+42.86%) | 70K |
Operating Income | |||||||||||||||||||||||||
Operating Income | -12.08M (+69.90%) | -7.11M (-73.26%) | -26.59M (+203.89%) | -8.75M (+46.08%) | -5.99M (+558.24%) | -910.00K (-55.39%) | -2.04M (-87.10%) | -15.82M (-13.22%) | -18.23M (-16.80%) | -21.91M (+12.36%) | -19.50M (+5.46%) | -18.49M (+19.21%) | -15.51M (+2.65%) | -15.11M (-15.49%) | -17.88M (-14.65%) | -20.95M (+23.53%) | -16.96M | 2.79M | -14.52M (+14.42%) | -12.69M (+30.56%) | -9.72M (-62.69%) | -26.05M (+318.14%) | -6.23M (+23.12%) | -5.06M (-29.53%) | -7.18M |
Ebit | -12.08M (+69.90%) | -7.11M (-73.26%) | -26.59M (+203.89%) | -8.75M (+46.08%) | -5.99M (+558.24%) | -910.00K (-55.39%) | -2.04M (-87.10%) | -15.82M (-13.22%) | -18.23M (-16.80%) | -21.91M (+12.36%) | -19.50M (+5.46%) | -18.49M (+19.21%) | -15.51M (+2.65%) | -15.11M (-15.49%) | -17.88M (-14.65%) | -20.95M (+23.53%) | -16.96M | 2.79M | -14.52M (+14.42%) | -12.69M (+30.56%) | -9.72M (-62.69%) | -26.05M (+318.14%) | -6.23M (+23.12%) | -5.06M (-29.53%) | -7.18M |
EBITDA | -12.08M (+25.44%) | -9.63M (-61.25%) | -24.85M (+228.27%) | -7.57M (+26.38%) | -5.99M (-29.61%) | -8.51M (+167.61%) | -3.18M (-48.71%) | -6.20M (-65.57%) | -18.01M (-26.94%) | -24.65M (+42.16%) | -17.34M (+1.34%) | -17.11M (+11.98%) | -15.28M (-1.67%) | -15.54M (-10.38%) | -17.34M (-15.37%) | -20.49M (+22.11%) | -16.78M | 3.05M | -14.42M (+14.54%) | -12.59M (+30.74%) | -9.63M (-62.99%) | -26.02M (+324.47%) | -6.13M (+23.59%) | -4.96M (-30.14%) | -7.10M |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Income | - | - | - | - | - | - | - | - | - | 2.84M (+31.48%) | 2.16M (+56.52%) | 1.38M (+89.04%) | 730K (-24.74%) | 970K (+76.36%) | 550K (+19.57%) | 460K (+170.59%) | 170K (+1600.00%) | 10K (0.00%) | 10K (0.00%) | 10K | - | - | - | - | - |
Net Interest Income | - | - | - | - | - | - | - | - | - | 2.84M (+31.48%) | 2.16M (+56.52%) | 1.38M (+89.04%) | 730K (-24.74%) | 970K (+76.36%) | 550K (+19.57%) | 460K (+170.59%) | 170K (+1600.00%) | 10K (0.00%) | 10K (0.00%) | 10K | - | - | - | - | - |
Other Non Operating Income | 340K (-52.78%) | 720K (-60.87%) | 1.84M (-60.93%) | 4.71M | - | 70K | -1.19M | 240K | -10.00K (-50.00%) | -20.00K | - | -10.00K | 570K (-73.36%) | 2.14M (+296.30%) | 540K (+17.39%) | 460K | -50.00K | 20K (+100.00%) | 10K (0.00%) | 10K | - | 260K (+2500.00%) | 10K (-50.00%) | 20K (-91.30%) | 230K |
Net Income | |||||||||||||||||||||||||
Income Before Tax | -10.61M (-11.73%) | -12.02M (-51.63%) | -24.85M (+803.64%) | -2.75M (-54.77%) | -6.08M (+69.83%) | -3.58M (+12.58%) | -3.18M (-76.74%) | -13.67M (-15.20%) | -16.12M (-17.96%) | -19.65M (+13.32%) | -17.34M (+1.34%) | -17.11M (+20.32%) | -14.22M (-79.32%) | -68.76M | - | - | - | - | - | - | - | - | - | - | - |
Income Tax Expense | 10K | -320.00K (+357.14%) | -70.00K | 20K (-33.33%) | 30K | -80.00K | - | 60K (+100.00%) | 30K | -160.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -10.62M (+53.69%) | -6.91M (-72.11%) | -24.78M (+226.91%) | -7.58M (+24.67%) | -6.08M (+26.40%) | -4.81M (+51.26%) | -3.18M (-49.20%) | -6.26M (-71.94%) | -22.31M (+14.47%) | -19.49M (+12.40%) | -17.34M (+1.34%) | -17.11M (+20.32%) | -14.22M (+0.85%) | -14.10M (-18.69%) | -17.34M (-15.37%) | -20.49M (+21.67%) | -16.84M | 2.80M | -14.51M (+14.43%) | -12.68M (+30.45%) | -9.72M (-62.69%) | -26.05M (+318.81%) | -6.22M (+23.41%) | -5.04M (-27.38%) | -6.94M |
Net Income | -10.62M (+53.69%) | -6.91M (-72.11%) | -24.78M (+226.91%) | -7.58M (+24.67%) | -6.08M (+26.40%) | -4.81M (+51.26%) | -3.18M (-49.20%) | -6.26M (-71.94%) | -22.31M (+14.47%) | -19.49M (+12.40%) | -17.34M (+1.34%) | -17.11M (+20.32%) | -14.22M (+0.85%) | -14.10M (-18.69%) | -17.34M (-15.37%) | -20.49M (+21.67%) | -16.84M | 2.80M | -14.51M (+14.43%) | -12.68M (+30.45%) | -9.72M (-62.69%) | -26.05M (+318.81%) | -6.22M (+23.41%) | -5.04M (-27.38%) | -6.94M |
Comprehensive Income Net Of Tax | -10.72M (-76.33%) | -45.29M (+83.43%) | -24.69M (+781.79%) | -2.80M (-54.02%) | -6.09M (-83.37%) | -36.61M (+1051.26%) | -3.18M (-76.91%) | -13.77M (-16.09%) | -16.41M (-75.67%) | -67.45M (+292.61%) | -17.18M (+0.59%) | -17.08M (+22.44%) | -13.95M (-79.94%) | -69.53M (+299.37%) | -17.41M (-17.57%) | -21.12M (+21.94%) | -17.32M (-49.22%) | -34.11M | - | - | - | - | - | - | - |